
Watch the on-demand webinar
The new guidelines on Y-chromosomal microdeletion testing
Watch the exclusive webinar, where renowned expert Prof. Csilla Krausz will delve into the 2023 AZF testing guidelines, how they impact AZF testing, and their clinical relevance.
About Prof. Krausz
A globally recognized leader in male infertility research, Prof. Krausz has identified a number of novel candidate genes on the X chromosome and autosomes, involved in non-obstructive azoospermia, and authored nearly 230 publications. She is the primary author of the EAA/EMQN guidelines on Y-chromosomal microdeletion analysis, her lab serves as the EMQN reference lab for the AZF testing scheme, and she has been one of the EMQN AZF scheme organizers for over 20 years.
Don’t miss this chance to gain insights from one of the field’s foremost authorities!
Latest from the Devyser blog
View all

Devyser launches a new updated NGS assay to simplify thalassemia testing
Devyser has launched Devyser Thalassemia v2, a next-generation sequencing (NGS) solution designed...
Read More

Devyser Thalassemia achieves 99.9% sensitivity: Insights from a recent study
Thalassemia and hemoglobinopathies are among the most common genetic disorders worldwide, affecting...
Read More

New insights into thalassemia: Latest studies using Devyser Thalassemia for NGS testing
Read More